Investing Profile

Michael Powell

InvestorVC
Executive Partner at Omega Funds
omegafunds.com/team/mike-powe...Boston, Massachusetts
Photo of Michael Powell, Partner at Omega Funds
Your Intro Paths to Michael Powell

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Michael Powell on

cb
Current Investing Position
Omega Funds Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
16

Michael Powell is on these Sector & Stage Rankings

Impact (Series B)Medical Devices (Series B)Consumer Health (Series B)Impact (Seed)Impact (Series A)Medical Devices (Series A)Medical Devices (Seed)Consumer Health (Series A)Consumer Health (Seed)Digital Health (Series B)Health IT (Series B)Health & Hospital Services (Series B)BioTech (Series B)Impact (Series B)Health & Hospital Services (Series A)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)Health IT (Series A)Health IT (Seed)Medical Devices (Series B)BioTech (Series A)BioTech (Seed)Consumer Health (Series B)Impact (Series A)Medical Devices (Series A)Impact (Seed)Medical Devices (Seed)BioTech (Series B)Digital Health (Series B)Health IT (Series B)Consumer Health (Series A)Health & Hospital Services (Series B)Consumer Health (Seed)Boston / New EnglandDigital Health (Series A)Digital Health (Seed)BioTech (Series A)Health & Hospital Services (Series A)BioTech (Seed)Health & Hospital Services (Seed)Health IT (Series A)Health IT (Seed)

Michael Powell's Investments On Record (10)

CompanyStageDateRound SizeTotal Raised
Aerium Therapeutics
Series AMar 2022
Co-investors: Stephen Knight (F-Prime Capital Partners), Vincent Ossipow (Omega Funds)
Checkmate Pharmaceuticals
Series CJun 2020$85M
Series BJun 2017$27M
Series AAug 2015$20M
$150M
Co-investors: Ben Auspitz (F-Prime Capital Partners), Corey Goodman (venBio), Daniel Coley (Cofounders Capital)
Veridium
Series BJun 2018$17M
$17M
Pionyr Immunotherapeutics
Series BDec 2017$62M
$79M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Arjun Goyal (Vida Ventures), Jack Kenney (SV Health Investors), Leon Chen (The Column Group)
Mirna Therapeutics
Series DApr 2015$42M
Series COct 2012$35M
$77M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Bill Harrington (Osage University Partners)
Labrys Biologics
Series AJan 2013$31M
Series UnknownDec 2012$15M
$46M
Co-investors: Wende Hutton (Canaan Partners), Nina Kjellson (Canaan Partners)
Intellikine
Series BJul 2009$51M
Series BJun 2007$30M
$81M
DiObex
Series BApr 2007$24M
Series ASep 2005$7M
$31M